Not manycompaniesthis size with2 late stageassetsWe haveenough cashto go wellinto 2023I/ONTAK waspreviouslyapproved buttaken off themarket to improvemanufacturing.Hemorrhoidsis a $2BmarketI won't diluteshareholdersI/ONTAKis our leadassetMino-Lokis our leadassetI/ONTAKwas thebest deal Iever madeAnymentionof Mino-WrapAn actualiMSCupdateThe name Citiuscomes from theOlympic motto"Citius,AltiusForius"We had aphase 2btrial with100%efficacyMino-Lokpotentialmarket>$1BWe expect tofinish theMino-Loktrial this yearI'm ashareholdermyselfThere are noFDAapproveddrugs to treathemorrhoidsMyron Holubiakand I founded aprivatecompany in2013Only biotechwith 2 Myron'son theleadershipteamWe intendto submita BLA in2H 2022We willhaveexclusivityI/ONTAK'spotentialmarket is>$300mInsidersinvested$26.5mOur Halo-Lido trial willhave finalpatient byend of 2022We will openupinternationalsites forMino-Lok trialNot manycompaniesthis size with2 late stageassetsWe haveenough cashto go wellinto 2023I/ONTAK waspreviouslyapproved buttaken off themarket to improvemanufacturing.Hemorrhoidsis a $2BmarketI won't diluteshareholdersI/ONTAKis our leadassetMino-Lokis our leadassetI/ONTAKwas thebest deal Iever madeAnymentionof Mino-WrapAn actualiMSCupdateThe name Citiuscomes from theOlympic motto"Citius,AltiusForius"We had aphase 2btrial with100%efficacyMino-Lokpotentialmarket>$1BWe expect tofinish theMino-Loktrial this yearI'm ashareholdermyselfThere are noFDAapproveddrugs to treathemorrhoidsMyron Holubiakand I founded aprivatecompany in2013Only biotechwith 2 Myron'son theleadershipteamWe intendto submita BLA in2H 2022We willhaveexclusivityI/ONTAK'spotentialmarket is>$300mInsidersinvested$26.5mOur Halo-Lido trial willhave finalpatient byend of 2022We will openupinternationalsites forMino-Lok trial

Leonard Mazur HCW Conference BINGO - Call List

(Print) Use this randomly generated list as your call list when playing the game. There is no need to say the BINGO column name. Place some kind of mark (like an X, a checkmark, a dot, tally mark, etc) on each cell as you announce it, to keep track. You can also cut out each item, place them in a bag and pull words from the bag.


1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
  1. Not many companies this size with 2 late stage assets
  2. We have enough cash to go well into 2023
  3. I/ONTAK was previously approved but taken off the market to improve manufacturing.
  4. Hemorrhoids is a $2B market
  5. I won't dilute shareholders
  6. I/ONTAK is our lead asset
  7. Mino-Lok is our lead asset
  8. I/ONTAK was the best deal I ever made
  9. Any mention of Mino-Wrap
  10. An actual iMSC update
  11. The name Citius comes from the Olympic motto "Citius,Altius Forius"
  12. We had a phase 2b trial with 100% efficacy
  13. Mino-Lok potential market >$1B
  14. We expect to finish the Mino-Lok trial this year
  15. I'm a shareholder myself
  16. There are no FDA approved drugs to treat hemorrhoids
  17. Myron Holubiak and I founded a private company in 2013
  18. Only biotech with 2 Myron's on the leadership team
  19. We intend to submit a BLA in 2H 2022
  20. We will have exclusivity
  21. I/ONTAK's potential market is >$300m
  22. Insiders invested $26.5m
  23. Our Halo-Lido trial will have final patient by end of 2022
  24. We will open up international sites for Mino-Lok trial